Synthesis of some derivatives of the open lactam from praziquantel and their in vitro/in vivo cyclization

Saudi Pharmaceutical Journal

Volumn 11, Issue 4, 2003, Pages 172-183

  Saeed, Ahmed E M ^a   A Karim, Elfatih ^a   Ahmed, Babiker M ^a   Ibrahim, Kamal E E ^a   Suleiman, Mutasim I ^c   Suleiman, Suad M ^b  

^a UNIVERSITY OF KHARTOUM   (Sudan)

^b National Health Laboratory   (Sudan)

^c NONE

Author keywords

Derivatives; PZQ; Synthesis

Indexed keywords

LACTAM; PRAZIQUANTEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHELMINTIC ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; CYCLIZATION; DERIVATIZATION; DRUG EFFECT; DRUG SYNTHESIS; HYDROLYSIS; NONHUMAN; ROOM TEMPERATURE; SCHISTOSOMIASIS; STRUCTURE ACTIVITY RELATION;

EID: 0347719313     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Stelma, F.F.; Sall, S.; Daff, B.; Sour, S.; Niang, M. and Gryseels, B. Oxamniquine cures Schistosoma mansoni infection in afocus in which cure rates with praziquantel are unusually low. J.Inf. Diseases, 1997; 176: 304-7.
2. Fallon, P.G.: Mubarak, J.S.; Fookes, R.E.; Niang, M.; Butterworth, A.E.; Strurrock, R.F. and Doenhaff, N.J. Schistosoma mansoni: Maturation and drug susceptibility of different geographic isolates. Experiment. Parasitol. 1997; 86: 29-36.
3. Cioli. D.; Pica-Mattoccia, L. and Archer, S. Antischistosomal drugs: past, present and future? Pharmacol. Therapeut. 1995; 68: 35-85.
4. Andrews, P.; Thomas H.; Pohlke, R, and Seubert, J. Praziquantel. Medicinal Research Reviews. 1983; 3: 147-200.
5. Putter. J. A fluorometric method for the determination of praziquantel in blood-plasma and urine. Eur. J. Drug Metabol. Pharmacok., 1979; 3: 143-148.
6. Saleh, H. and Schnekenburger J. Colorimetric method for the quantitative determination of the antibilharzial drug praziquantel and its application to pharmaceutical preparations. Analyst. 1992 ; 117: 87-92.